PRO-ACT houses the largest ALS clinical trials dataset ever created. PRO-ACT consists of over 8,500 ALS patient records from 18 completed Phase II and Phase III clinical trials conducted by companies including Sanofi, Teva, Novartis, and Regeneron.
Launch PRO-ACT >
The ALSGene database provides a comprehensive, unbiased and regularly updated field synopsis of genetic association studies performed in ALS.
Launch ALSGene >
Watch for additional tools, demonstration videos, and other infrastructural resources that can help scientists move research forward quickly.